← All stocks

TELA Bio, Inc.

TELA Net buying
CIK 0001561921 #4919 in the set updated 17 Sep 2026
Bought (120 mo)
$51.77M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$4.22M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$4.22M
7 of 7 sales
Net
+$47.55M
+$47.55M against sales at will

By person

32 insiders · 254 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EW HEALTHCARE PARTNERS FUND 2, L.P. entity
10% owner
$35.56M (186)
+$35.56M
14,340,779
31.94%
$15.18M
+84.3%
Opaleye Management Inc. entity
Former 10% Owner.
$3.95M (36)
+$3.95M
124,813
0.2780%
$132.15K
Oliva Adele C
Director
$2.00M (1)
+$2.00M
1,751,100
3.90%
$1.85M
+138.3%
Quaker BioVentures II LP entity
10% owner
$2.00M (1)
+$2.00M
0
0.0000%
$0.00
−100.0%
ORBIMED ADVISORS LLC entity
10% owner
$5.00M (1)
$3.81M (6)
+$1.19M
5,434,784
12.11%
$5.75M
+29.0%
Azarbarzin Kurt
Director
$1.12M (2)
+$1.12M
532,951
1.19%
$564.29K
+184.4%
Zuga Matt
Director
$1.12M (2)
+$1.12M
514,481
1.15%
$544.73K
+174.6%
Cuca Roberto
COO and CFO
$327.80K (7)
+$327.80K
257,377
0.5733%
$272.51K
+3,876%
KOBLISH ANTONY
Chief Executive Officer
$249.97K (2)
+$249.97K
586,210
1.31%
$620.68K
RTW INVESTMENTS, LP entity
10% owner
$277.12K (1)
$407.62K (1)
−$130.50K
1,139,358
2.54%
$1.21M
−1.1%
Capper Joseph H
Director
$78.44K (2)
+$78.44K
104,827
0.2335%
$110.99K
Talmo Paul
Chief Technology Officer
$50.00K (1)
+$50.00K
173,436
0.3863%
$183.63K
+469.2%
Firestone Gregory A.
Chief Business Officer
$29.69K (2)
+$29.69K
139,307
0.3103%
$147.50K
+623.4%
Getz Heather C
Chief Executive Officer
$18.78K (2)
+$18.78K
532,500
1.19%
$563.81K
+10,550%
Ellis Ronald J. Jr.
Director
774,056
1.72%
$819.57K
+299.6%
Friedman Ashley
Director
611,333
1.36%
$647.28K
+130.0%
Blizard Jeffrey
President
205,125
0.4569%
$217.19K
PERSENAIRE MAARTEN
Chief Medical Officer
90,887
0.2024%
$96.23K
+56.4%
Smeykal Megan
Chief Accounting Officer
66,873
0.1490%
$70.81K
+581.1%
Murphy Peter C.
Chief Commercial Officer
48,129
0.1072%
$50.96K
+13,269%
Plovanic William J.
Director
44,530
0.0992%
$47.15K
Greenhalgh Ellis Skott
Chief Technology Officer
27,826
0.0620%
$29.46K
+673.4%
THOMAS PAUL
Director
23,600
0.0526%
$24.99K
NEELS GUIDO J
Director
23,600
0.0526%
$24.99K
NOHRA GUY P
Director
23,600
0.0526%
$24.99K
Rocchio Betty Jo
Director
23,600
0.0526%
$24.99K
Burgess Vincent J
Director
23,330
0.0520%
$24.70K
O'Brien Federica F.
Director
18,470
0.0411%
$19.56K
EVANS DOUGLAS G
Director
18,470
0.0411%
$19.56K
COLLERAN LISA N
Director
18,470
0.0411%
$19.56K
Brennan Nora
Chief Financial Officer
17,696
0.0394%
$18.74K
+9,898%
Nosenzo John
Director
6,270
0.0140%
$6.64K
Insider
Date
Role
Action
Shares
Price
Amount
ORBIMED ADVISORS LLC
2 Jul 2024
10% owner
Sell indirect
36,600
$4.54
$166.16K
ORBIMED ADVISORS LLC
1 Jul 2024
10% owner
Sell indirect
13,700
$4.68
$64.12K
ORBIMED ADVISORS LLC
28 Jun 2024
10% owner
Sell indirect
378,000
$4.74
$1.79M
ORBIMED ADVISORS LLC
21 Apr 2023
10% owner
Sell indirect
27,700
$9.41
$260.66K
ORBIMED ADVISORS LLC
20 Apr 2023
10% owner
Sell indirect
28,300
$9.43
$266.87K
ORBIMED ADVISORS LLC
19 Apr 2023
10% owner
Sell indirect
136,000
$9.30
$1.26M
RTW INVESTMENTS, LP
17 Dec 2019
10% owner
Sell indirect
36,000
$11.32
$407.62K
Showing 250 of 254 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 232
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 74
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 8,659,818
Sales filed before the plan box existed 1
History held since 13 Nov 2019